List of bibliographic references
Number of relevant bibliographic references: 20.
| Ident. | Authors (with country if any) | Title |
|---|
| 000234 (2000) |
Susan H. Fox ; Jonathan M. Brotchie | 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease |
| 000344 (2001) |
Susan H. Fox ; Brian Henry ; Micheal P. Hill ; David Peggs ; Alan R. Crossman ; Jonathan M. Brotchie | Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan |
| 000478 (2002) |
Susan H. Fox ; Mark Kellett ; A. Peter Moore ; Alan R. Crossman ; Jonathan M. Brotchie | Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |
| 000602 (2002) |
Joanne E. Nash ; Jonathan M. Brotchie | Characterisation of striatal NMDA receptors involved in the generation of Parkinsonian symptoms: Intrastriatal microinjection studies in the 6-OHDA-lesioned rat |
| 000779 (2003) |
Gregorio Segovia ; Francisco Mora ; Alan R. Crossman ; Jonathan M. Brotchie | Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease |
| 000897 (2003) |
Juha-Matti Savola ; Michael Hill ; Mia Engstrom ; Hannele Merivuori ; Siegfried Wurster ; Steven G. Mcguire ; Susan H. Fox ; Alan R. Crossman ; Jonathan M. Brotchie | Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease |
| 000A42 (2003) |
Michael P. Hill ; Erwan Bezard ; Steven G. Mcguire ; Alan R. Crossman ; Jonathan M. Brotchie ; Ann Michel ; Renee Grimee ; Henrik Klitgaard | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset |
| 000F03 (2005) |
Jonathan M. Brotchie | Nondopaminergic mechanisms in levodopa-induced dyskinesia |
| 001200 (2006) |
Jordi Gomez-Ramirez ; Tom H. Johnston ; Naomi P. Visanji ; Susan H. Fox ; Jonathan M. Brotchie | Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease |
| 001352 (2006) |
Susan H. Fox ; Anthony E. Lang ; Jonathan M. Brotchie | Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies : Keys to success and roads to failure |
| 001404 (2006) |
Naomi P. Visanji ; Jordi Gomez-Ramirez ; Tom H. Johnston ; Donna Pires ; Valerie Voon ; Jonathan M. Brotchie ; Susan H. Fox | Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease |
| 001440 (2006) |
Michael P. Hill ; Paula Ravenscroft ; Steven G. Mcguire ; Jonathan M. Brotchie ; Alan R. Crossman ; Catherine Rochat ; Mark J. Millan | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets : Mediation by D2, not D3, dopamine receptors |
| 001722 (2007) |
Giovanni Fabbrini ; Jonathan M. Brotchie ; Francisco Grandas ; Masahiro Nomoto ; Christopher G. Goetz | Levodopa-induced dyskinesias |
| 001C42 (2008) |
Naomi P. Visanji ; Rob M. A. De Bie ; Tom H. Johnston ; Andrew C. Mccreary ; Jonathan M. Brotchie ; Susan H. Fox | The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease |
| 001E93 (2009) |
Susan H. Fox ; Rosalind Chuang ; Jonathan M. Brotchie | Serotonin and Parkinson's Disease: On Movement, Mood, and Madness |
| 002323 (2010) |
Philippe Huot ; Tom H. Johnston ; Tayyeba Darr ; Lili-Naz Hazrati ; Naomi P. Visanji ; Donna Pires ; Jonathan M. Brotchie ; Susan H. Fox | Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations |
| 002327 (2010) |
Tom H. Johnston ; Anne Van Der Meij ; Jonathan M. Brotchie ; Susan H. Fox | Effect of Histamine H2 Receptor Antagonism on Levodopa-Induced Dyskinesia in the MPTP-Macaque Model of Parkinson's Disease |
| 002426 (2010) |
Tom H. Johnston ; Susan H. Fox ; Matthew J. Piggott ; Juha-Matti Savola ; Jonathan M. Brotchie | The α2 Adrenergic Antagonist Fipamezole Improves Quality of Levodopa Action in Parkinsonian Primates |
| 002757 (2011) |
James B. Koprich ; Susan H. Fox ; Tom H. Johnston ; Allan Goodman ; Bertrand Le Bourdonnec ; Roland E. Dolle ; Robert N. Dehaven ; Diane L. Dehaven-Hudkins ; Patrick J. Little ; Jonathan M. Brotchie | The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease |
| 002B28 (2012) |
Philippe Huot ; Tom H. Johnston ; Naomi P. Visanji ; Tayyeba Darr ; Donna Pires ; Lili-Naz Hazrati ; Jonathan M. Brotchie ; Susan H. Fox | Increased Levels of 5-HT1A Receptor Binding in Ventral Visual Pathways in Parkinson's Disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "BROTCHIE (Jonathan M.)"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i \
-Sk "BROTCHIE (Jonathan M.)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Merge
|type= indexItem
|index= FA11s1.i
|clé= BROTCHIE (Jonathan M.)
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
